id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S5066 R13191 |
De Lorenzo (Controls unexposed, disease free), 2020 | Malformations | at least 1st trimester | retrospective cohort | unexposed, disease free excluded | Adjustment: No |
7.67 [0.21;278.90] C excluded (control group) |
0/2 1/36 | 1 | 2 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S5067 R13197 |
De Lorenzo (Controls unexposed, sick), 2020 | Malformations | at least 1st trimester | retrospective cohort | unexposed, sick | Adjustment: No | 21.00 [0.30;1469.95] C | 0/2 0/32 | 0 | 2 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S5069 R15979 |
Chambers (Controls unexposed, disease free), 2019 | Major Birth Defects | at least 1st trimester | prospective cohort | unexposed, disease free excluded | Adjustment: Yes |
1.43 [0.33;6.27] excluded (control group) |
22/221 12/198 | 34 | 221 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S5068 R15980 |
Chambers (Controls, sick), 2019 | Major Birth Defects | at least 1st trimester | prospective cohort | unexposed, sick | Adjustment: Yes | 1.10 [0.45;2.73] | 22/221 8/106 | 30 | 221 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3006 R11357 |
Hoxha, 2017 | Congenital malformation | 1st trimester | prospective cohort | unexposed, sick | Adjustment: No | 2.50 [0.12;50.45] C | 1/5 1/11 | 2 | 5 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S4061 R11349 |
Bröms (controls unexposed, disease free), 2016 | Any major birth defect | 3 months or more before pregnancy or1st trimester | population based cohort retrospective | unexposed, disease free excluded | Adjustment: No |
1.35 [0.69;2.64] C excluded (control group) |
9/161 52,592/1,250,192 | 52,601 | 161 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3197 R11350 |
Bröms (controls unexposed, sick), 2016 | Any major birth defect | 3 months or more before pregnancy or1st trimester excluded | population based cohort retrospective | unexposed, sick | Adjustment: Yes |
1.22 [0.58;2.27] excluded (exposition period) |
9/161 1,019/21,549 | 1,028 | 161 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2911 R11361 |
Weber-Schoendorfer, 2015 | Major birth defects | 1st trimester | prospective cohort | unexposed, disease free | Adjustment: No | 4.15 [1.86;9.23] C | 9/150 21/1,385 | 30 | 150 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3090 R11353 |
Casanova, 2013 | Congenital malformations (NOS) | 3 months (or more) before pregnancy or during pregnancy excluded | retrospective cohort | exposed to other treatment, sick | Adjustment: No |
21.13 [1.26;354.49] C excluded (exposition period) |
1/16 1/318 | 2 | 16 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S13724 R53458 |
Viktil (Controls exposed to other treatments), 2012 | Major malformations | 3 months or more before pregnancy or1st trimester | population based cohort propective | exposed to other treatment, sick excluded | Adjustment: No |
5.57 [0.26;117.63] C excluded (control group) |
0/3 50/1,458 | 50 | 3 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S13725 R53460 |
Viktil (Controls unexposed, NOS), 2012 | Major malformations | 3 months or more before pregnancy or1st trimester excluded | population based cohort propective | unexposed (general population or NOS) | Adjustment: No |
6.00 [0.29;124.97] C excluded (exposition period) |
0/3 5,000/154,976 | 5,000 | 3 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3121 R4855 |
Schnitzler (Unexposed control, disease free), 2011 | Malformations (NOS) | 3 months (or more) before pregnancy or during pregnancy | prospective cohort | unexposed, disease free excluded | Adjustment: No |
30.27 [1.10;836.04] C excluded (control group) |
1/7 0/56 | 1 | 7 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3122 R4856 |
Schnitzler (Unexposed control, sick), 2011 | Malformations (NOS) | 3 months (or more) before pregnancy or during pregnancy excluded | prospective cohort | unexposed, sick | Adjustment: No |
12.83 [0.71;231.76] C excluded (exposition period) |
1/7 1/78 | 2 | 7 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S5001 R15981 |
Hyrich, 2006 | Major fetal abnormalities | 1st trimester | retrospective cohort | unexposed, sick | Adjustment: No | 5.00 [0.07;366.35] C | 0/2 0/8 | 0 | 2 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 5 studies | 2.51 [1.06;5.97] | 62 | 380 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Controls unexposed, sick; 2: Controls, sick;
Asymetry test p-value = 0.6440 (by Egger's regression)
slope=0.6141 (0.6738); intercept=0.5249 (1.0254); t=0.5119; p=0.6440
excluded 3121, 13724, 4061, 5069, 5066